$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Renal artery stenosis (RAS) is a leading cause of secondary hypertension and constitutes a significant risk factor for cardiovascular morbidity1. A primary challenge in clinical research is the difficulty in delineating the causal pathway connecting dyslipidemia, hypertension, and end-organ damage, as comorbidities and concurrent medications frequently confound patient studies. This underscores the critical need for an animal model that accurately recapitulates this complex pathophysiology in a controlled, reproducible experimental setting.
The two-kidney, one-clip (2K1C) Goldblatt model is a well-established method for inducing renovascular hypertension in rodents. However, conventional species such as mice and rats present considerable limitations. Notably, these rodents lack cholesteryl ester transfer protein (CETP), a key enzyme in human high-density lipoprotein metabolism2. As a result, they are resistant to diet-induced hypercholesterolemia and atherosclerosis, failing to mimic the metabolic profile commonly observed in patients with RAS. Furthermore, the hypertensive response to renal artery clipping in these models is often attenuated and highly variable; for instance, C57BL/6 mice exhibit a minimal blood pressure increase, while Sprague-Dawley rats show considerable inter-individual variability, which impedes reproducible mechanistic and therapeutic investigations3,4.
In contrast, the Syrian golden hamster (Mesocricetus auratus) possesses unique physiological advantages for such research. Its natural expression of CETP enables the development of a human-like lipoprotein profile, including elevated LDL-C and slightly increased HDL-C, upon feeding a high-fat and high-cholesterol diet, leading to the spontaneous formation of atherosclerotic lesions in the aorta and coronary arteries5. This provides a highly relevant metabolic and vascular background for studying cardiovascular disease. Moreover, recent evidence indicates that hamsters mount a significantly more robust blood pressure response to renin-angiotensin-aldosterone system (RAAS) activation compared to mice, and chymase, making them particularly suitable for hypertension research6.
Despite these advantages, the utility of the hamster 2K1C model has been limited by the lack of a standardized and survivable surgical protocol. Existing techniques, which range from complete ligation with high mortality rates to operator-dependent partial ligation, yield inconsistent results and poor reproducibility7. Therefore, to fully exploit the hamster’s dual susceptibility to metabolic and hypertensive disease, we developed a refined and highly reproducible surgical approach for the 2K1C model. This optimized protocol ensures consistent induction of hypertension against a background of diet-induced dyslipidemia, thereby offering a robust and integrated experimental platform to investigate the synergistic effects of RAS, hyperlipidemia, and cardiovascular injury.